Marco Giaisi Selected Research

Marco Giaisi Research Topics

Disease

12	Neoplasms (Cancer) 01/2017 - 12/2006
4	Leukemia 01/2017 - 12/2006
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2017 - 08/2012
3	Inflammation (Inflammations) 01/2010 - 09/2002
2	Thrombocytopenia (Thrombopenia) 01/2016 - 02/2015
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2016 - 05/2006
2	Lymphoma (Lymphomas) 02/2015 - 08/2012
2	T-Cell Leukemia (Leukemia, T Cell) 02/2015 - 02/2008
1	Multiple Myeloma 01/2017
1	Neoplasm Metastasis (Metastasis) 08/2016
1	Lymphoid Leukemia 02/2015
1	Wilms Tumor (Wilm's Tumor) 01/2014
1	Hodgkin Disease (Hodgkin's Disease) 08/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Colonic Neoplasms (Colon Cancer) 01/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Melanoma (Melanoma, Malignant) 01/2012
1	Hematologic Neoplasms (Hematological Malignancy) 02/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2007
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2007
1	Kaposi Sarcoma (Kaposi's Sarcoma) 08/2007
1	Asthma (Bronchial Asthma) 06/2005
1	Skin Diseases (Skin Disease) 06/2005
1	Hypersensitivity (Allergy) 09/2002

Drug/Important Bio-Agent (IBA)

5	rocaglamideIBA 01/2017 - 10/2007
4	wogoninIBA 02/2015 - 12/2006
3	Proteins (Proteins, Gene)FDA Link 04/2014 - 05/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 12/2006
2	navitoclaxIBA 01/2016 - 02/2015
2	chrysinIBA 02/2015 - 01/2012
2	ApigeninIBA 02/2015 - 01/2012
2	FlavonesIBA 02/2015 - 01/2012
2	LigandsIBA 08/2012 - 01/2012
2	Antineoplastic Agents (Antineoplastics)IBA 08/2012 - 01/2012
2	Interleukin-4 (Interleukin 4)IBA 01/2010 - 09/2002
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2017
1	PhytochemicalsIBA 08/2016
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 08/2016
1	antineoplaston A10 (A 10)IBA 01/2016
1	DiterpenesIBA 12/2015
1	LuteolinIBA 02/2015
1	baicaleinIBA 02/2015
1	venetoclaxIBA 02/2015
1	Apoptosis Regulatory ProteinsIBA 02/2015
1	WT1 ProteinsIBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Fas Ligand Protein (Fas Ligand)IBA 01/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2012
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2012
1	CytokinesIBA 01/2010
1	Mitogen-Activated Protein KinasesIBA 10/2007
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2007
1	p38 Mitogen-Activated Protein KinasesIBA 10/2007
1	Pharmaceutical PreparationsIBA 08/2007
1	ArtesunateIBA 08/2007
1	Antimalarials (Antimalarial Agents)IBA 08/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2007
1	Cycloheximide (Cicloheximide)IBA 12/2006
1	Protein Synthesis InhibitorsIBA 12/2006
1	Free RadicalsIBA 12/2006
1	Dactinomycin (Actinomycin)FDA LinkGeneric 12/2006
1	NF-kappa B (NF-kB)IBA 12/2006
1	Trans-Activators (Trans-Acting Factor)IBA 05/2006
1	parthenolideIBA 12/2002
1	Vitamin E FDA LinkGeneric 09/2002
1	Immunoglobulin E (IgE)IBA 09/2002
1	IgE Receptors (Fc epsilon RI)IBA 09/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 08/2016 - 08/2007
4	Therapeutics 01/2017 - 02/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2008
1	Traditional Medicine (Folk Remedies) 06/2005